Veru Investor Relations Material
Latest events
Q1 2024
Veru
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Veru Inc
Access all reports
Segment Data
Access more data
Net revenue by
Category
U.S. prescription channel
Global public health sector
Other
Expenses by
Financials
Veru, Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company's lead product is currently in Phase III clinical trials, and it has also initiated Phase II trials with additional compounds targeting other therapeutic areas. Veru's clinical development pipeline includes two compounds formulated with cationic polymers, one of which was designed to improve the delivery of a select class of cancer therapeutics. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States